Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025
Pelthos Therapeutics (NYSE American: PTHS) will report third quarter 2025 financial results and host a conference call on Thursday, November 13, 2025 at 8:00 a.m. Eastern Time.
The company said a press release with financial results will be issued prior to the call. Management will discuss results for the quarter ended September 30, 2025, followed by a Q&A session. Dial-in details: toll-free 1-877-451-6152, international 1-201-389-0879, Conference ID 13756828. A live webcast will be available at the provided webcast URL.
Pelthos Therapeutics (NYSE American: PTHS) comunicherà i risultati finanziari del terzo trimestre 2025 e terrà una conference call giovedì 13 novembre 2025 alle 8:00 ora della costa orientale.
La società ha dichiarato che emetterà un comunicato stampa con i risultati prima della chiamata. Il management discuterà dei risultati del trimestre terminato il 30 settembre 2025, seguito da una sessione di domande e risposte. Dettagli per la dial-in: linea gratuita 1-877-451-6152, internazionale 1-201-389-0879, ID conferenza 13756828. Una webcast in diretta sarà disponibile all'URL fornito per il webcast.
Pelthos Therapeutics (NYSE American: PTHS) reportará los resultados financieros del tercer trimestre de 2025 y organizará una conferencia telefónica el jueves 13 de noviembre de 2025 a las 8:00 a.m. hora del Este.
La empresa indicó que emitirá un comunicado de prensa con los resultados antes de la llamada. La dirección ejecutiva discutirá los resultados del trimestre finalizado al 30 de septiembre de 2025, seguido de una sesión de preguntas y respuestas. Detalles de marcación: línea gratuita 1-877-451-6152, internacional 1-201-389-0879, ID de conferencia 13756828. Una retransmisión en vivo estará disponible en la URL de webcast proporcionada.
Pelthos Therapeutics (NYSE American: PTHS)는 2025년 3분기 재무 실적을 발표하고 2025년 11월 13일 목요일 동부 표준시 기준 오전 8시(ET)에 컨퍼런스 콜을 개최합니다.
회사 측은 콜 이전에 재무 실적이 담긴 보도자료를 발표하겠다고 밝혔습니다. 경영진은 2025년 9월 30일 종료된 분기의 실적을 논의하고 이어 질의응답 세션이 진행됩니다. 다이얼 인 정보: 무료 1-877-451-6152, 국제 1-201-389-0879, 회의 ID 13756828. 제공된 웹캐스트 URL에서 라이브로 청취할 수 있습니다.
Pelthos Therapeutics (NYSE American: PTHS) publiera les résultats financiers du troisième trimestre 2025 et animera une conférence téléphonique le jeudi 13 novembre 2025 à 8 h 00, heure de l'Est.
La société a indiqué qu'un communiqué de presse présentant les résultats serait publié avant l'appel. La direction discutera des résultats du trimestre clos au 30 septembre 2025, suivie d'une séance de questions-réponses. Détails pour l'accès: sans frais 1-877-451-6152, international 1-201-389-0879, ID de conférence 13756828. Une webdiffusion en direct sera disponible à l'URL fournie.
Pelthos Therapeutics (NYSE American: PTHS) wird die Finanzergebnisse des dritten Quartals 2025 berichten und am Donnerstag, dem 13. November 2025 um 8:00 Uhr Ostzeit eine Telefonkonferenz veranstalten.
Das Unternehmen gab an, vor dem Call eine Pressemitteilung mit den Finanzergebnissen zu veröffentlichen. Das Management wird die Ergebnisse des Quartals zum 30. September 2025 besprechen, gefolgt von einer Fragerunde. Dial-in Details: gebührenfrei 1-877-451-6152, international 1-201-389-0879, Conference ID 13756828. Eine Live-Webcast wird unter der angegebenen Webcast-URL verfügbar sein.
Pelthos Therapeutics (NYSE American: PTHS) ستصدر نتائج الربع الثالث من عام 2025 وستعقد مكالمة مؤتمر يوم الخميس 13 نوفمبر 2025 في الساعة 8:00 صباحاً بتوقيت Eastern.
قالت الشركة إنه سيتم إصدار بيان صحفي يحتوي على النتائج قبل المكالمة. ستناقش الإدارة نتائج الربع المنتهي في 30 سبتمبر 2025، تليها جلسة أسئلة وأجوبة. تفاصيل الاتصال: الخط المجاني 1-877-451-6152، الدولي 1-201-389-0879، معرف المؤتمر 13756828. ستكون هناك بث مباشر عبر الويب متاح على عنوان الـ webcast المقدم.
- None.
- None.
Company to hold a conference call at 8:00 a.m. ET
DURHAM, N.C., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”), will hold a conference call on Thursday, November 13, 2025, at 8:00 a.m. Eastern Time to discuss its results for the third quarter period ended September 30, 2025. The financial results will be issued in a press release prior to the call.
Pelthos management will host the call, followed by a question-and-answer period. Details for the conference call can be found below:
| Date: Time: Toll Free: International: Conf.ID: | Thursday, November 13, 2025 8:00 a.m. Eastern Time 1-877-451-6152 1-201-389-0879 13756828 |
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1740524&tp_key=723fef088c
About Pelthos Therapeutics
Pelthos Therapeutics is a biopharmaceutical company committed to commercializing innovative, safe, and efficacious therapeutic products to help patients with unmet treatment burdens. The company’s lead product ZELSUVMI™ (berdazimer) topical gel,
Contacts
Investors:
Mike Moyer
Managing Director, LifeSci Advisors, LLC
mmoyer@lifesciadvisors.com
Media:
KWM Communications
Kellie Walsh
pelthos@kwmcommunications.com
(914) 315-6072
FAQ
When will Pelthos Therapeutics (PTHS) report Q3 2025 results and hold the conference call?
How can investors join the Pelthos (PTHS) November 13, 2025 conference call?
Where can I watch the Pelthos (PTHS) Q3 2025 earnings webcast?
What will Pelthos management cover on the November 13, 2025 call for PTHS?
Will Pelthos (PTHS) release the Q3 2025 financial press release before the conference call?
